Lack of association VNTR polymorphism of dopamine transporter gene (SLC6A3) and schizophrenia in a Brazilian sample

Arquivos de Neuro-Psiquiatria

Volumn 62, Issue 4, 2004, Pages 973-976

  Cordeiro, Quirino ^a   Talkowski, Michael ^b   Wood, Joel ^b   Ikenaga, Eliza ^a   Vallada, Homero ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

DAT1; Genetic association; Genetic polymorphism; Schizophrenia; SLC6A3; Trios

Indexed keywords

DOPAMINE TRANSPORTER;

ALLELE; ARTICLE; BRAZIL; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; GENE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; PROGENY; SCHIZOPHRENIA; SLC6A3 GENE; VARIABLE NUMBER OF TANDEM REPEAT;

EID: 10944239451     PISSN: 0004282X     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0004-282X2004000600008     Document Type: Article

References (44)

1. McGuffin F, Owen MJ, O'Donovan MC, Thapar A, Gottesman I. Seminars in psychiatric genetics. London: Royal College of Psychaitrists, 1994.
2. Frederickson A. The dopamine hypothesis of schizophrenia. Second Web Rep 1998.
3. Goodwin FK, Jamison KR. Manic-depressive illness. New York: Oxford University Press, 1990.
4. Murphy DL, Brodie HK, Goodwin FK, Bunney WE. Regular induction of hypomania by L-DOPA in bipolar manic-depressive patients. Nature 1971;229:135-136.
5. Brown AS, Gershon S. Dopamine and depression. J Neural Transm Genet Sec 1993;91:75-109.
6. Emilien G, Maloteaux JM, Geurts M, Owen MJ. Dopamine receptors and schizophrenia: contribution of molecular genetics and clinical neuropsychology. Int J Neuropsychopharm 1999;2:197-227.
7. Cordeiro Q Jr, Junqueira R, Vallada H. Study of association between the ser-9-gly polymorphism of the D3 dopaminergic receptor and schizophrenia. Arq Neuropsiquiatr 2001;59:219-222.
8. Lung FW, Tzeng DS, Shu BS. Ethnic heterogeneity in allele variation in the DRD4 gene in schizophrenia. Schizophr Res 2002;57:239-245.
9. Glatt SJ, Faraone SV, Tsuang MT. Meta-analysis identifies an association between the dopamine D2 receptor gene and schizophrenia. Mol Psychiatry 2003;8:911-915.
10. Jonsson EG, Sillen A, Vares M, Ekholm B, Terenius L, Sedvall GC. Dopamine D2 receptor gene Ser311Cys variant and schizophrenia: association study and meta-analysis. Am J Med Genet 2003;119:28-34.
11. Jonsson EG, Flyckt L, Burgert E, et al. Dopamine D3 receptor gene Ser9Gly variant and schizophrenia: association study and meta-analysis. Psychiatr Genet 2003;13:1-12.
12. Jonsson EG, Sedvall GC, Nothen MM, Cichon S. Dopamine D4 receptor gene (DRD4) variants and schizophrenia: meta-analyses. Schizophr Res 2003;61:111-119.
13. Jaber M, Jones S, Giros B, Caron MG. The dopamine transporter: a crucial component regulating dopamine transmission. Movement Disord 1997;12:629-633.
14. Laakso A, Bergman J, Haaparanta M, et al. Decreased striatal dopamine transporter binding in vivo in chronic schizophrenia. Schizophr Res 2001;52:115-120.
15. Knable MB, Hyde TM, Herman MM, Carter JM, Bigelow L, Kleinman JE. Quantitative autoradiography of dopamine-D1 receptors, D2 receptors, and dopamine uptake sites in postmortem striatal specimens from schizophrenic patients. Biol Psychiatry 1994;36:827-835.
16. Chinaglia G, Alvarez FJ, Probst A, Palacios JM. Mesostriatal and mesolimbic dopamine uptake binding sites are reduced in Parkinson's disease and progressive supranuclear palsy: a quantitative autoradiographic study using [3H]mazindol. Neuroscience 1992;49:317-327.
17. Giros B, Mestikawy S, Godinot N, et al. Cloning, pharmacological characterization, and chromosome assignment of the human dopamine transporter. Mol Pharmacol 1992;42:383-390.
18. Byerley W, Coon H, Hoff M, et al. Human dopamine transporter gene not linked with schizophrenia in multigenerational pedigrees. Hum Hered 1993;43:319-322.
19. Byerley W, Hoff M, Holik J, Caron MG, Giros B. VNTR polymorphism for the human dopamine transporter gene (DAT1). Hum Mol Genet 1993;2:335.
20. Persico AM, Wang ZW, Black DW, Andreasen NC, Uhl GR, Crowe RR. Exclusion of close linkage of the dopamine transporter gene with schizophrenia spectrum disorders. Am J Psychiatry 1995;152:134-136.
21. Bodeau-Pean S, Laurent C, Campion D, et al. No evidence for linkage or association between the dopamine transporter gene and schizophrenia in a French population. Psychiatry Res 1995;59:1-6.
22. Maier W, Minges J, Eckstein N, et al. Genetic relationship between dopamine transporter gene and schizophrenia: linkage and association. Schizophr Res 1996;20:175-180.
23. Semwal P, Prasad S, Bhatia T, et al. Family-based association studies of monoaminergic gene polymorphisms among North Indians with schizophrenia. Mol Psychiatry. 2001;6:220-224.
24. Li T, Yang L, Wiese C. No association between alleles or genotypes at the dopamine transporter gene and schizophrenia. Psychiatry Res 1994;52:17-23.
25. Daniels J, Williams J, Asherson P, McGuffin P, Owen M. No association between schizophrenia and polymorphisms within the genes for debrisoquine 4-hydroxylase (CYP2D6) and the dopamine transporter (DAT). Am J Med Genet 1995;60:85-87.
26. Joober R, Toulouse A, Benkelfat C, et al. DRD3 and DAT1 genes in schizophrenia: an association study. J Psychiatr Res 2000;34:285-291.
27. Inada T, Sugita T, Dobashi I, et al. Dopamine transporter gene polymorphism and psychiatric symptoms seen in schizophrenic patients at their first episode. Am J Med Genet 1996;26:406-408.
28. Georgieva L, Dimitrova A, Nikolov I, et al. Dopamine transporter gene (DAT1) VNTR polymorphism in major psychiatric disorders: family-based association study in the Bulgarian population. Acta Psychiatr Scand 2002;105:396-399.
29. Hauser J, Kapelski P, Czerski PM, et al. Lack of association between VNTR polymorphism of DAT gene and schizophrenia. Psychiatr Pol 2002;36:403-412.
30. Semwal P, Prasad S, Varma PG, Bhagwat AM, Deshpande SN, Thelma BK. Candidate gene polymorphisms among North Indians and their association with schizophrenia in a case-control study. J Genet 2002;81:65-71.
31. Persico AM, Macciardi F. Genotypic association between dopamine transporter gene polymorphisms and schizophrenia. Am J Med Genet 1997;74:53-57.
32. Blum K, Braverman ER, Wu S, et al. Association of polymorphisms of dopamine D2 receptor (DRD2), and dopamine transporter (DAT1) genes with schizoid/avoidant behaviors (SAB). Mol Psychiatry 1997;2:239-246.
33. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th edn. Washington, DC: American Psychiatric Association, 1994.
34. Sham PC, Curtis D. Monte Carlo tests for associations between disease and alleles at highly polymorphic loci. Ann Hum Genet 1995;59:97-105.
35. Sham PC, Curtis D. An extended transmission/disequilibrium test (TST) for multi-allele marker loci. Ann Hum Genet 1995;59:323-336.
36. North BV, Curtis D, Sham PC. A note on the calculation of empirical p-values from Monte Carlo procedures. Am J Hum Genet 2002;71:445-7.
37. Shan P. Statistics in human genetics. New York: Arnold, 1998.
38. Persico AM, Bird G, Gabbay FH, Uhl GR. D2 dopamine receptor gene TaqI A1 and B1 restriction fragment length polymorphisms: enhanced frequencies in psychostimulant-preferring polysubstance abusers. Biol Psychiatry 1996;40:776-784.
39. Parra FC, Amado RC, Lambertucci JR, Rocha J, Antunes CM, Pena SD. Color and genomic ancestry in Brazilians. Proc Natl Acad Sci U S A 2003;100:177-182.
40. Spielman R, Ewens W. The T.D.T. and other family-based tests for linkage disequilibrium and association. Am J Hum Genet 1996;59:983-989.
41. Kelsoe JR, Sadovnick AD, Krisbjarnarson H. Possible locus for bipolar disorder near the dopamine transporter on chromosome 5. Am J Med Genet 1996;67:533-540.
42. Waldman ID, Robinson BF, Feigon SA. Linkage disequilibrium between the dopamine transporter gene (DAT1) and bipolar disorder: extending the transmission disequilibrium test (TDT) to examine genetic heterogeneity. Genet Epidemiol 1997;14:699-704.
43. Greenwood TA, Alexander M, Keck PE, et al. Evidence for linkage disequilibrium between the dopamine transporter and bipolar disorder. Am J Med Genet 2001;105:145-151.
44. Gelernter J, Kranzler HR, Satel SL, Rao PA. Genetic association between dopamine transporter protein alleles and cocaine-induced paranoia. Neuropsychopharmacology 1994;11:195-199.